Drug pricing reform in China: analysis of piloted approaches and potential impact of the reform

OBJECTIVES: In 2009, the Chinese government launched a national healthcare reform programme aiming to control healthcare expenditure and increase the quality of care. As part of this programme, a new drug pricing reform was initiated on 1 June 2015. The objective of this study was to describe the ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yixi, Hu, Shanlian, Dong, Peng, Kornfeld, Åsa, Jaros, Patrycja, Yan, Jing, Ma, Fangfang, Toumi, Mondher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802695/
https://www.ncbi.nlm.nih.gov/pubmed/27123191
http://dx.doi.org/10.3402/jmahp.v4.30458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802695/
https://www.ncbi.nlm.nih.gov/pubmed/27123191
http://dx.doi.org/10.3402/jmahp.v4.30458

Ejemplares similares